Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Juan Lopez-Belmonte Encina | Chairman & CEO | 1.62M | -- | -- |
| Mr. Ivan Lopez-Belmonte Encina | Second Deputy Chairman & GM of Commercial and Development | 716.69k | -- | -- |
| Mr. Javier Lopez-Belmonte Encina | First Deputy Chairman, GM of Industrial Operations & CFO | 723.32k | -- | -- |
| Ms. Marta Campos Martínez | Head of Investor Relations | -- | -- | -- |
| Ms. Mercedes Benítez del Castillo Sánchez | Legal Department Manager | -- | -- | -- |
| Ms. Beatriz Ávila Alcalde | Sales Manager | -- | -- | -- |
| Ms. Rosario Perucha Pérez | Marketing Manager | -- | -- | -- |
| Mr. Francisco Javier Angulo García | Human Resources Manager | -- | -- | -- |
| Mr. Gabriel Nunez Fernandez | Secretary | -- | -- | -- |
Laboratorios Farmaceuticos Rovi, S.A.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 2,197
Description
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, aseptic filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Its products are used for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Corporate Governance
Upcoming Events
May 8, 2025 at 6:30 AM UTC
Laboratorios Farmaceuticos Rovi, S.A. Earnings Date
Recent Events
July 8, 2024 at 12:00 AM UTC
Ex-Dividend Date